Origin: The APOE3 targeted replacement mouse was developed in the laboratory of Nobuya Maeda at the University of North Carolina. The model was created by targeting the murine Apoe gene for replacement with the human APOE3 allele in E14TG2a ES cells and injecting the targeted cells into blastocysts. Resultant chimeras were backcrossed to C57BL/6 for seven generations (N7). Taconic received stock in 2000. The mice were backcrossed once more (N8) and embryo transfer derived. The colony is maintained through incrossing of homozygotes.
Genetics: Carries Nnt mutation
Initial Publication: Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem, 272(9):17972-80.
Animal Diet: NIH #31M Rodent Diet
Label License: Conditions of Use for Taconic Transgenic Models™
|4 to 8||$305.10||$305.10|
|9 to 12||$312.40||$312.40|
Contact Us or call: